Beta-D-Galactose pentaacetate Cas:114162-64-0 99% Pauda keʻokeʻo
| Helu Helu | XD90045 |
| inoa mea kūʻai | Beta-D-Galactose pentaacetate |
| CAS | 4163-60-4 |
| ʻĀpana Molekala | C14H13BrClNO7 · C6H13N |
| Kaumaha Molecular | 521.80 |
| Nā kikoʻī mālama | Ambient |
Huahana Huahana
| Ka nana aku | Pauda keʻokeʻo |
| Hoʻāʻo | 99% |
| Kūlana Kūlana | 200 |
| waihonaTemp | −20°C |
Nā waiwai:ʻO ia ka pauka crystalline keʻokeʻo, ʻaʻole hiki ke hoʻoheheʻe ʻia i ka wai a maʻalahi hoʻi e hoʻoheheʻe ʻia i ka ethanol, chloroform etc.
Hoʻohana:Hoʻohana nui ʻia ka β-D-Galactose pentaacetate i ka hopena biochemical a hoʻohana ʻia ma ke ʻano he lāʻau lapaʻau waena.Penei:
1. β-D-Galactose pentaacetate i hoʻohana ʻia i ka synthesis o 3-carbethoxyphenyl-beta-D-acetylated galactoside.Hoʻohana ʻia ka pūhui no ka mālama ʻana i ke kaumaha.
2. Hoʻohana ia i ka synthesis o 1,2-glycoside transderivative o nā pūhui oxazole.Hiki ke hoʻohana ʻia ma ke ʻano he lāʻau antineoplastic e kāohi ana i ka hui microtubule a koho i nā kīʻaha koko koko.
3. Hoʻohana ʻia ia i ka synthesis o kahi derivative glycolipid acid rupesonic.Hoʻomākaukau ʻia ka derivative ma ka synthetizing acid rupesonic a me ka acetylized glycosyl bromide e like me nā mea maka.Hōʻike ka hopena hoʻāʻo he ʻoi aku ka maikaʻi o ka pale ʻana o nā pūhui 2d a me 2g i nā maʻi maʻi influenza A (H3N2), a ʻoi aku ka maikaʻi o nā huaʻai 3 i nā maʻi influenza A (H3N2 a me H1N1) a me B.
4. Hoʻohana ia i ka synthesis o β-D-galactosamine pentaacetate ma ke ʻano he lāʻau lapaʻau waena.
5. Hoʻohui ʻia o ka galactose nitric oxide i hoʻokuʻu lohi i ka hydrogel no ka mālama ʻana i ka periodontitis
6. ʻO ka hoʻohuihui ʻana o ka trimethylcitryl--D-galactopyranoside hou he mau hopena hoʻopaneʻe ma ka ʻōnaehana nerve waena.
7. Hiki ke ho'ohana 'ia ka zein a me ka glycopolypeptide copolymer grafted i ho'omākaukau 'ia no ka ho'omākaukau 'ana i ka membrane fibrous electrospun e like me ke 'ano o ka scaffold ma ke 'ano o ka hana electrospinning.
8. Hoʻohui ʻia o ka 18F-labeled galactose derivative ma ke ʻano he mea noiʻi PET hou no ke kiʻi ʻana i ka ʻimi asialoglycoprotein receptor, kahi e hiki ai i ka ʻimi ke lilo i mea hana kiʻi glucose metabolism ʻē aʻe i hoʻohana ʻia i ka hoʻokolokolo a me ka helu helu.
9. Hoʻohui ʻia o nā polymers sugar sulfated hou no ka mālama ʻana a/a i ʻole ka hoʻoponopono ʻana i ka mumū, a i ʻole no ka mālama ʻana a/a i ʻole ka pale ʻana i ka ischemia, me ka mālama ʻana a/a i ʻole ka pale ʻana i ka ʻeha ischemia-reperfusion a i ʻole ischemic stroke, ka mālama ʻana i ka maʻi kanesa, a no ka hoʻololi kino.
10. Hoʻohana ʻia no ka synthesis o ka tenofovir derivatives, he hopena antiviral, hiki ke noʻonoʻo i loko o ke ake a hoʻokuʻu mālie i nā mea hana, ʻoi aku ka maikaʻi o ka hana lāʻau, haʻahaʻa haʻahaʻa.
11. ʻO ke ʻano a me ka ʻōnaehana hoʻopuka lāʻau o kahi nano-micelle me ka pale pale ligand ʻelua i hoʻopaʻa ʻia no ka mālama ʻana i ka maʻi kanesa.
12. Hiki ke hoʻohana 'ia e like me ka mea o ka proximal pāpale o vascular pani pani.
13. Ua hoʻohana ʻia i ka synthesis o isopropyl-beta-D-thiogalactoside (IPTG) ma ke ʻano he inducer ikaika.A i ʻole synthesis o ka hōʻike protein inducible ʻoi aku ka paʻa o ka thiogalactoside IBCG, hoʻohana ʻia no ka hoʻoulu ʻana i ka hōʻike gene e hana i kahi protein recombinant ma ke ʻano he pani hana no IPTG.
14. Ua hoʻohana ʻia i ka synthesis o 4-methyl umbrella-shaped keto-beta-D-pyran galactoside.He substrate fluorescent koʻikoʻi i hoʻohana ʻia e ʻike i nā coliforms i ka wai a me ka meaʻai.Ma ke ʻano he substrate glycosidase, hiki ke hoʻohana ʻia no ka nānā ʻana i ka hana o ka glycosidase e pili ana a me ke aʻo ʻana i ka ʻike microbiological o ka glycosidase kikoʻī e like me kahi hōʻailona koʻikoʻi.
15. He pani waihoʻoluʻu β-galactosidase i hoʻomākaukau ʻia me ka hoʻohana ʻana i ka 4-nitro-1-naphthol a i ʻole ka mea i loaʻa ma ke ʻano he chromophore.
16. Hoʻohana ʻia ia no ka hoʻomākaukau ʻana i nā pūhui fluorescent, a hoʻohana i ka pūhui fluorescent e hoʻomākaukau i kahi kiʻiʻoniʻoni ʻike e ʻike ai i ka ʻike koʻikoʻi o ka mahu hydrogen chloride.
17. Hoʻohana ʻia ia i ka synthesis o 1-thio-phenyl-2,3,4-tri-O-benzyl-O-substituent acyl-1-deoxy-β-D-galactose ester ma ke ʻano he mea hāʻawi i ka galactose ester.
18. Hoʻohana ʻia ia no ka hoʻomākaukau ʻana i nā polysaccharides i hoʻopili ʻia e ka novel oxime a me ka hoʻomākaukau ʻana o 6-azide -2, 4-diacetyl amino-2, 4, 6-trideoxy d-mannose.
19. Hoʻomākaukau i nā nanofibers glycosylated no ka ʻike protein.
20. Hoʻohana ʻia ia no nā mea hoʻopaʻa paʻa hou no ka hoʻoheheʻe ʻana i nā metala a no ka hoʻoheheʻe ʻana i nā ʻāpana metala a me nā ʻāpana seramika.
